KDA
ABBV icon

Kraft Davis & Associates’s AbbVie ABBV Stock Holding History

Kraft Davis & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Hold
944
– – 0.05% 139
2026
Q1 		$201K Sell
944
-261
-22% -$57.9K 0.04% 150
2025
Q4 		$266K Buy
+1,205
New +$275K 0.06% 130

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Kraft Davis & Associates's ABBV Position: Q2 2026 in Review

Kraft Davis & Associates held its AbbVie (ABBV) position steady in Q2 2026 at 944 shares worth $239K. The position accounts for 0.05% of the portfolio, ranked #139.

Kraft Davis & Associates first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $266K in Q4 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kraft Davis & Associates held 944 shares of AbbVie worth $239K as of Q2 2026.
  • Kraft Davis & Associates left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.05% of Kraft Davis & Associates's portfolio in Q2 2026, its #139 holding.
  • Kraft Davis & Associates first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Kraft Davis & Associates's AbbVie position peaked at $266K in Q4 2025.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kraft Davis & Associates's 13F filing for Q2 2026, filed 9 Jul 2026.